191.53
price down icon1.25%   -2.4175
 
loading

Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
13.46%
505.13
445.22 361.63 315.27 264.71
Operating Income/Loss
13.46%
-505.13
-445.22 -361.63 -315.27 -264.71
Nonoperating Income/Loss
1,520%
-139.24
-8.594 -3.266 10.06 16.93
Income/Loss From Continuing Operations Before Tax
41.99%
-644.37
-453.82 -364.89 -305.21 -247.79
Net Income/Loss
41.99%
-644.37
-453.82 -364.89 -305.21 -247.79
Basic Average Shares
6.46%
210.89
198.10 1.4716 189.23 188.58
Diluted Average Shares
6.46%
210.89
198.10 1.4716 189.23 188.58
Basic Earnings Per Share
33.62%
-3.06
-2.29 -1.89 -1.61 -1.31
Diluted Earnings Per Share
33.62%
-3.06
-2.29 -1.89 -1.61 -1.31
ONC ONC
$351.43
price up icon 0.29%
$805.25
price down icon 0.87%
$224.00
price down icon 1.33%
$56.83
price down icon 1.64%
$34.23
price down icon 1.04%
$37.13
price down icon 0.64%
Kapitalisierung:     |  Volumen (24h):